| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0007 |